Patents by Inventor Anker Jorgensen

Anker Jorgensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment and Prevention of Major Adverse Cardiovascular Events or Major Coronary Events by Administering Omega-3 Fatty Acids
    Publication number: 20110092552
    Abstract: Omega-3 fatty acid compositions comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are provided, where the compositions are useful for treating, reducing the occurrence of, or preventing major adverse cardiovascular events or major coronary events in patients who have established cardiovascular disease without prior myocardial infarction, preventing their further progression, and treating underlying risk factors for CVD such as hypertension, dyslipidemia, obesity and/or diabetes.
    Type: Application
    Filed: December 23, 2010
    Publication date: April 21, 2011
    Inventors: My SVENSSON, Jeppe Hagstrup Christensen, Erik Berg Schmidt, Kaj Anker Jorgensen
  • Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids
    Publication number: 20080306154
    Abstract: Omega-3 fatty acid compositions comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are provided, where the compositions are useful for treating, reducing the occurrence of, or preventing major adverse cardiovascular events or major coronary events in patients who have established cardiovascular disease without prior myocardial infarction, preventing their further progression, and treating underlying risk factors for CVD such as hypertension, dyslipidemia, obesity and/or diabetes.
    Type: Application
    Filed: November 5, 2007
    Publication date: December 11, 2008
    Inventors: My Svensson, Jeppe Hagstrup Christensen, Erik Berg Schmidt, Kaj Anker Jorgensen
  • Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids
    Publication number: 20080125490
    Abstract: Compositions comprising omega-3 fatty acids are provided, where the compositions are useful for treating cardiovascular disease in patients suffering from chronic kidney disease (CKD), preventing its further progression, and treating underlying risk factors such as hypertension, dyslipidemia, obesity and/or diabetes. Also provided are methods of using the compositions to reduce the occurrence of or prevent major coronary events, including myocardial infarctions, in patients with CKD.
    Type: Application
    Filed: November 5, 2007
    Publication date: May 29, 2008
    Inventors: My Svensson, Jeppe Hagstrup Christensen, Erik Berg Schmidt, Kaj Anker Jorgensen
  • 11beta-hydroxysteroid dehydrogenase type 1 active compounds
    Publication number: 20060089349
    Abstract: A novel class of compounds of the general formula (I), their use in therapy, pharmaceutical compositions comprising the compounds, as well as their use in the manufacture of medicaments are described. The present compounds modulate the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) and are accordingly useful in the treatment of diseases in which such a modulation is beneficial, e.g. the metabolic syndrome.
    Type: Application
    Filed: October 6, 2005
    Publication date: April 27, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Anette Gundertofte, Anker Jorgensen, Gita, Camilla Kampen, Henrik Andersen, Inge Christensen, John Kilburn
  • Glucagon antagonists/inverse agonists
    Publication number: 20050059611
    Abstract: A novel class of compounds, which act to antagonize the action of the glucagon hormone on the glucagon receptor. Owing to their antagonizing effect of the glucagon receptor the compounds may be suitable for the treatment and/or prevention of any diseases and disorders, wherein a glucagon antagonistic action is beneficial, such as hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism and obesity.
    Type: Application
    Filed: October 12, 2004
    Publication date: March 17, 2005
    Applicant: Novo Nordisk A/S
    Inventors: Anker Jorgensen, Peter Madsen